INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2013

Potassium citrate supplementation for 24 months improved bone density, microarchitecture, and FRAX scores in healthy older adults.

In a randomized, double-blind, placebo-controlled trial, 201 healthy older adults without osteoporosis were assigned to 60 mEq of oral potassium citrate daily or placebo for 24 months alongside calcium and vitamin D. Potassium citrate increased lumbar spine areal BMD from baseline by 1.7 ± 1.5% net of placebo (95% CI 1.0-2.3, P < 0.001). Trabecular densities also increased at the nondominant tibia (1.3 ± 1.3%, P < 0.001) and nondominant radius (2.0 ± 2.0%, P < 0.001), alongside improvements in trabecular bone volume/tissue volume (0.9 ± 0.8%), thickness (1.5 ± 1.6%), and number (1.9 ± 1.8%, all P < 0.05). Potassium citrate also significantly decreased FRAX fracture prediction scores in both sexes.

Study type
Randomized, double-blind, placebo-controlled trial
Who was studied
201 healthy men and women over 65 years old without osteoporosis
What was measured
Lumbar spine areal BMD, volumetric density, microarchitecture, FRAX score

THE PAPER

Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial.

Jehle S, Hulter HN, Krapf R. J Clin Endocrinol Metab, 2013.

PubMed 23162100 ↗DOI 10.1210/jc.2012-3099 ↗

Healthy aging & longevityBones & muscles

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.